Tongji Hospital Tongji Medical College of HUST — Wuhan, Hubei

Public research footprint of Tongji Hospital Tongji Medical College of HUST, compiled from the ClinicalTrials.gov public registry.

104

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer (NSCLC) · Multiple Myeloma · Neovascular Age-Related Macular Degeneration (nAMD) · Carcinoma, Non-Small-Cell Lung

Recently updated registry entries

NCT07317934 — Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related… (Recruiting)
NCT05920356 — A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum… (Recruiting)
NCT07276399 — A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Tongji Hospital Tongji Medical College of HUST?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.